Russia’s healthcare infrastructure will continue witnessing significant rise in number of orthopaedic patients as several bone & joint-related disorders are likely to be caused by people’s eating & drink habits, their proactive lifestyles and the country’s harsh weather conditions. Rising occurrence of joint-related ailments such as knee osteoarthritis in Russia are a result of people performing physical labour in severely cold weather conditions. This has necessitated the adoption of viscosupplementation as an ideal medical procedure for injecting lubricating fluid in bone joints during surgeries. An in-depth analysis of Russia’s viscosupplementation market, conducted by Future Market Insights, projects that demand for three-injection viscosupplementation will gain traction over the next decade.
Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-ru-2897
According to Future Market Insights’ recent report, titled “Viscosupplementation Market: Russia Industry Analysis and Opportunity Assessment, 2016-2026,” nearly 70% of viscosupplementation revenues amassed across Russia in 2016 were accounted by three-injection viscosupplementation. The report estimates that the Russian viscosupplementation market incurred revenues worth over RUB 1.13 billion (US$ 19 million) in 2016. Registering a steady increment at 5.8% CAGR, Russia’s viscosupplementation revenues are expected to reach RUB 2.02 billion (US$ 34 million) by the end of 2026. With higher demand for three-injection viscosupplementation, Russia’s healthcare industry leaders will continue to extend production of three-injection viscosupplementation products as opposed to single injection and five-injection viscosupplementation products.
The report also establishes projections regarding the end-use of viscosupplementation in Russia. Hospitals across the country will account for just above RUB 1.24 billion (US$ 21 million) revenues by the end of projection period. Within this, the demand for viscosupplementation will remain considerably higher in hospitals with capacity of more than 500 beds. End-use of viscosupplementation in Russia’s ambulatory surgical centres (ASCs) will remain nascent, while revenues accounted by orthopaedic clinics are expected to surpass RUB 595 million (US$ 10 million) through 2026.
Top Players in Russia’s Viscosupplementation Market: Top three established players in Russia’s Viscosupplementation market include Hyaltech, Croma-Pharma GmbH and TRB Chemedica. The market is fragmented with small players holding substantial market share. While Hyaltech, Croma-Pharma GmbH and TRB Chemedica collectively dominate with more than half of the country’s viscosupplementation revenues. International players such as Sanofi, Ferring Pharmaceuticals and Fidia Farmaceutici spa have low share as compared to the other players, Anika Therapeutics has recently launched their viscosupplementation product in Russia’s viscosupplementation market.
Request for a Customization of This Report @ https://www.futuremarketinsights.com/customization-available/rep-ru-2897
Our unique research methodology identifies potential resources from a sales and delivery perspective in the Russia viscosupplementation market
The report highlights the performance of the viscosupplementation market in Russia and provides a detailed outlook for every market segment for 2016–2026 in terms of market size, Y-o-Y growth rates, absolute $ opportunity and BPS analysis. We have considered 2015 as the base year and provided data for the next 10 years. In addition, it is imperative to note that given the ever-fluctuating nature of the Russian economy, we have not only conducted the market forecast in terms of CAGR but have also provided an analysis of the Russia viscosupplementation market based on key parameters such as year-on-year (Y-o-Y) growth rates to understand the predictability of the market and to identify the right opportunities across the Russia viscosupplementation market.
Further, market segments in terms of product type and end user have been analysed in terms of Basis Point Share (BPS) to understand the segmental contribution to market growth. This detailed level of information is important for identifying various key trends emerging in the Russia viscosupplementation market. Another useful feature of this report is the analysis of key segments in terms of absolute dollar opportunity, critical in assessing the level of opportunity that market players can look to achieve, as well as to identify potential resources from a sales and delivery perspective in the Russia viscosupplementation market.